# Apertus Pharmaceuticals – FDA Inspection, Oct 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/apertus-pharmaceuticals/d2159b71-ad5c-474a-a568-a403b00cb157
Source feed: FDA_Inspections

> FDA inspection 1293102 of Apertus Pharmaceuticals, October 31, 2025. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293102
- Company Name: Apertus Pharmaceuticals
- Inspection Date: 2025-10-31
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Kansas City District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1119160 - 2020-01-16](https://www.keypedia.com/records/fda_inspections/apertus-pharmaceuticals/69ebf067-fc54-434c-b431-ecc838356afd)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)

Company: https://www.keypedia.com/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79
